Aslı Köse

Aslı Köse

Valdori Content Team
...
Views
Read Time
Transthyretin Amyloidosis Symptoms: Best Guide

Transthyretin amyloidosis (ATTR) is a rare disease. It happens when the body’s organs and tissues build up misfolded transthyretin protein. The Medical organization says amyloidosis is a rare disease that occurs when a protein called amyloid builds up in organs, affecting their function.transthyretin amyloidosis symptomsGastrointestinal Amyloidosis: What to Know

This condition makes proteins misfold in various organs. This leads to symptoms that can be hard to diagnose.

At Liv Hospital, we know how important early diagnosis and treatment are. Spotting the key symptoms early and getting a professional check-up is key to managing this condition well.

Key Takeaways

  • Transthyretin amyloidosis is a rare and progressive disease.
  • It is caused by genetic mutations in the TTR gene.
  • Early diagnosis is key for effective management.
  • The condition affects many organs, like the heart and nerves.
  • Getting a professional check-up is vital when you notice key symptoms.

Understanding Transthyretin Amyloidosis (ATTR)

Transthyretin Amyloidosis Symptoms: Best Guide

ATTR, or transthyretin amyloidosis, is a condition where the transthyretin protein misfolds. It then builds up in different parts of the body. We will look at the basics of this condition, including the role of transthyretin protein and how amyloid deposits form. We will also see which organs are commonly affected.

What Is Transthyretin Protein?

Transthyretin (TTR) is a protein mainly made in the liver. It helps transport thyroxine (T4) and retinol-binding protein in the blood. More than 100 different genetic mutations in the TTR gene can alter the structure of transthyretin, causing ATTR.

How Amyloid Deposits Form

When the TTR gene mutates, it can cause the transthyretin protein to misfold. This leads to amyloid fibrils forming. These fibrils then deposit in various tissues, causing organ dysfunction. The process involves complex biochemical changes, resulting in amyloid deposits.

Organs Commonly Affected

Transthyretin amyloidosis can affect many organs, including the heart, nerves, and gastrointestinal tract. Ruberg and Berk (2012) explain that transthyretin cardiac amyloidosis occurs when abnormal transthyretin protein builds up in the heart muscle. This leads to restrictive cardiomyopathy and can cause heart failure.

The Genetic Basis of Transthyretin Amyloidosis

Transthyretin Amyloidosis Symptoms: Best Guide

Transthyretin amyloidosis is caused by mutations in the TTR gene. This condition, also known as ATTR, leads to amyloid deposits in the body’s tissues. These deposits form when the transthyretin protein misfolds, which is produced in the liver.

TTR Gene Mutations

Mutations in the TTR gene result in abnormal transthyretin protein. Ando et al. (2013) found that hereditary ATTR amyloidosis is caused by these mutations. Over 100 TTR gene mutations can lead to ATTR, with some being more common in certain groups.

Common TTR Gene Mutations:

  • Val30Met: Associated with early-onset hereditary ATTR
  • Val122Ile: More common in individuals of African descent
  • Thr60Ala: Found in some European populations

Inherited vs. Wild-Type ATTR

Transthyretin amyloidosis is divided into two types: hereditary (hATTR) and wild-type (ATTRwt). Hereditary ATTR is caused by TTR gene mutations, while wild-type ATTR occurs without these mutations.

Characteristics

Hereditary ATTR (hATTR)

Wild-Type ATTR (ATTRwt)

Genetic Basis

Caused by TTR gene mutations

No TTR gene mutations

Age of Onset

Variable, often earlier

Typically older age

Family History

Often present

Absent

Genetic Testing and Family History

Genetic testing is key in diagnosing hereditary ATTR. It helps confirm the diagnosis and guides family screening. Those with a family history of ATTR should get genetic counseling and testing.

Understanding transthyretin amyloidosis’s genetic basis is vital for early diagnosis and management. Identifying at-risk individuals and providing genetic counseling can improve outcomes for those affected.

Types of Transthyretin Amyloidosis

ATTR amyloidosis comes in two main types: hereditary transthyretin-mediated amyloidosis (hATTR) and wild-type transthyretin amyloidosis (ATTRwt). Knowing these types helps doctors choose the right treatment and predict how the disease will progress.

Hereditary ATTR (hATTR)

Hereditary transthyretin amyloidosis (hATTR) is caused by a mutation in the TTR gene. This mutation leads to the production of abnormal transthyretin protein. It’s inherited in an autosomal dominant pattern, meaning only one copy of the mutated gene is needed to cause the disease.

The symptoms of hATTR can vary a lot among people, even in the same family. This difference is due to the specific mutation and other genetic and environmental factors.

Wild-Type ATTR (ATTRwt)

Wild-type ATTR (ATTRwt) happens without any TTR gene mutations. It’s more common in older men and often linked to heart problems. The exact cause of ATTRwt is not fully known, but it’s thought to be related to aging.

ATTRwt usually starts with heart symptoms like heart failure and irregular heartbeats. Some people may also have symptoms like carpal tunnel syndrome.

Differences in Progression and Prognosis

The way hATTR and ATTRwt progress and their prognosis are different. hATTR can start at any age, depending on the mutation, and can affect many organs, including the heart, nerves, and digestive system. The outcome for hATTR depends on the mutation and the organs affected.

ATTRwt, on the other hand, usually starts later in life and mainly affects the heart. It progresses slower than hATTR but is also very serious and can be deadly.

Characteristics

Hereditary ATTR (hATTR)

Wild-Type ATTR (ATTRwt)

Cause

TTR gene mutation

No TTR gene mutation

Age of Onset

Varies (often earlier)

Typically older age

Organ Involvement

Multi-organ (heart, nerves, GI tract)

Primarily cardiac

Progression

Variable, can be rapid

Generally slower

Gender Predominance

No specific gender predominance

Males more commonly affected

It’s key to understand the differences between hATTR and ATTRwt to manage transthyretin amyloidosis well. Knowing the exact type of ATTR is vital for making treatment plans and improving patient care.

Cardiac Manifestations of Transthyretin Amyloidosis

Transthyretin amyloidosis affects the heart in many ways. It can cause heart failure, arrhythmias, and cardiomyopathy. This condition can lead to serious health issues and even death. We will look at the symptoms and complications it can cause.

Heart Failure Symptoms

Heart failure is a serious issue in transthyretin amyloidosis. Symptoms include shortness of breath, chest pain, and ankle swelling. These happen because the heart can’t pump blood well, causing fluid buildup.

Siddiqi and Ruberg (2017) say cardiac amyloidosis can make the heart stiff. This stiffness makes it hard for the heart to fill with blood. It can lead to heart failure symptoms, even if the heart is pumping okay.

Arrhythmias and Conduction Disorders

Arrhythmias and conduction disorders are common in transthyretin amyloidosis. Palpitations and abnormal heart rhythms are common complaints. The amyloid deposits can mess with the heart’s electrical pathways, causing arrhythmias like atrial fibrillation and ventricular tachycardia.

Also, amyloid can affect the heart’s conduction system, leading to conduction blocks. This might need a pacemaker. We need to watch these patients for arrhythmias and conduction disorders, as they can greatly affect their health.

Cardiomyopathy and Structural Changes

Transthyretin amyloidosis can change the heart’s structure, leading to cardiomyopathy. The amyloid deposits make the heart muscle thick and stiff. This condition, known as transthyretin amyloid cardiomyopathy, can cause heart failure and arrhythmias.

Imaging like echocardiography and MRI is key for diagnosing and monitoring these changes. These tests can show the heart’s thickened walls and poor diastolic function.

Transthyretin Amyloidosis Symptoms Affecting the Nervous System

Transthyretin amyloidosis (ATTR) can harm the nervous system a lot. It causes many bad symptoms. These symptoms fall into two main groups: peripheral neuropathy and autonomic nervous system dysfunction.

Peripheral Neuropathy

Peripheral neuropathy is a big problem in ATTR. It damages the nerves outside the brain and spinal cord. People might have trouble walking, feel tingling or numbness in their hands and feet, and have weak or painful limbs.

This condition can make life very hard. It can make walking hard, cause numbness, and lead to pain. Benson and Kincaid (2007) say it can really hurt because it affects both feeling and movement nerves.

The nerve damage from ATTR can get worse. This can make it hard to do everyday things. People might feel numb, have weak muscles, and feel a lot of pain.

  • Numbness and tingling sensations in extremities
  • Muscle weakness, mainly in the legs
  • Pain, which can be severe and debilitating
  • Difficulty walking or maintaining balance

Autonomic Nervous System Dysfunction

ATTR also messes with the autonomic nervous system. This system controls things like digestion and heart rate. Problems here can cause stomach issues, low blood pressure when standing up, and sex problems.

A study on amyloid neuropathy shows how big of a deal autonomic problems are. They can make life very hard. Symptoms include stomach issues, low blood pressure, and sex problems.

System Affected

Symptoms

Gastrointestinal

Diarrhea, constipation, nausea

Cardiovascular

Orthostatic hypotension, syncope

Genitourinary

Urinary retention, sexual dysfunction

“Autonomic dysfunction in ATTR amyloidosis can lead to a wide range of symptoms that significantly impact the patient’s quality of life.”

Dealing with these symptoms needs a full plan. This includes medicine and support. Knowing how ATTR affects the nervous system helps doctors find better treatments.

Gastrointestinal and Digestive Symptoms

Transthyretin amyloidosis can really mess with your gut, causing a bunch of digestive problems. It affects the autonomic nervous system, leading to symptoms like diarrhea, nausea, and weight loss.

Diarrhea and Malabsorption

Diarrhea is a big problem for people with transthyretin amyloidosis. It happens because amyloid builds up in the intestines, making it hard to absorb nutrients. The Medical organization says amyloidosis can also cause constipation, making life tough for patients.

Malabsorption means your body can’t get enough nutrients from food. This can lead to weight loss. In transthyretin amyloidosis, it’s because amyloid blocks the gut or messes with how the gut moves.

Nausea and Early Satiety

Nausea is a big issue for those with transthyretin amyloidosis. It’s often because the stomach muscles are weak, causing food to stay in the stomach too long. Feeling full too soon is another problem, caused by the same issues.

“Gastrointestinal manifestations of amyloidosis can include nausea, vomiting, and abdominal pain, significantly impacting patients’ nutritional status and overall well-being.”

Weight Loss and Nutritional Challenges

Weight loss is a big worry for people with transthyretin amyloidosis. It’s because they can’t absorb nutrients well, eat less due to nausea or feeling full, and burn more energy. They often need special diets or supplements to feel better.

Symptom

Possible Cause

Management Strategy

Diarrhea

Amyloid deposits in intestines

Dietary adjustments, medication

Nausea

Gastroparesis, autonomic dysfunction

Medications for nausea, dietary changes

Weight Loss

Malabsorption, decreased intake

Nutritional supplements, dietary counseling

Gastrointestinal Motility Issues

Gastrointestinal motility problems, like gastroparesis and intestinal pseudo-obstruction, can happen in transthyretin amyloidosis. These are caused by amyloid and problems with the autonomic nervous system. They make eating hard and can make it hard to get the nutrients you need.

Dealing with gastrointestinal symptoms in transthyretin amyloidosis is complex. It’s important to have a full care plan. Knowing what causes these symptoms helps doctors help patients better.

Early Warning Signs and Diagnostic Challenges

Spotting early signs of transthyretin amyloidosis is vital for quick diagnosis and treatment. This disease often shows nonspecific symptoms that can be mistaken for other conditions. This makes it hard to catch early.

Carpal Tunnel Syndrome as a Precursor

Carpal tunnel syndrome is an early sign of transthyretin amyloidosis. It causes numbness and tingling in the hand. This can signal the start of more serious disease symptoms.

Research shows that people with this amyloidosis often get carpal tunnel syndrome years before other symptoms appear. As noted by Conceição et al. (2016), “men over 50 with carpal tunnel should be checked for wild-type transthyretin amyloidosis.”

Spinal Stenosis and Joint Issues

Spinal stenosis and joint problems are also early signs. These can cause pain and limit movement. Doctors need to see these symptoms as possible signs of the disease.

Misdiagnosis and Delayed Detection

Despite these early signs, transthyretin amyloidosis is often misdiagnosed or diagnosed late. Its symptoms are not specific, leading to delays in finding the right diagnosis. This can harm patient outcomes.

Misdiagnosis can lead to wrong treatments and missed opportunities for timely care.

Red Flags for Healthcare Providers

Doctors should watch for certain signs that might point to transthyretin amyloidosis. Look for carpal tunnel syndrome, spinal stenosis, and other symptoms like weight loss and stomach problems. Knowing these signs can help doctors diagnose and treat the disease sooner.

As we learn more about transthyretin amyloidosis, it’s clear that catching it early is critical. Recognizing early signs and understanding the challenges in diagnosis can help doctors improve patient care.

Symptom Variations Based on ATTR Type and Mutation

The symptoms of transthyretin amyloidosis (ATTR) can change a lot based on the type and mutation. This makes it hard to diagnose and treat, as each patient shows different signs. We will look at how symptoms differ by ATTR type, where people live, when symptoms start, and how these affect how fast the disease gets worse and quality of life.

Geographic and Ethnic Patterns

Some mutations are more common in certain places and ethnic groups. For example, the Val30Met mutation is often seen in Portugal, Sweden, and Japan. Other mutations, like Ala60Thr, are more common in Ireland. These patterns are important for doctors to know when diagnosing patients from different backgrounds.

According to Schmidt et al. (2016), the global spread of transthyretin familial amyloid polyneuropathy shows big differences by place and ethnicity.

“The spread of transthyretin familial amyloid polyneuropathy (TTR-FAP) changes a lot in different places, with some mutations more common in certain areas.”

Knowing these patterns helps doctors find and treat patients early and better.

Age of Onset Differences

When ATTR symptoms start can vary a lot. Hereditary ATTR (hATTR) often starts in a person’s 30s or 40s, but can start later. Wild-type ATTR (ATTRwt) usually starts later, after 60. The age when symptoms start is very important for knowing how fast the disease will get worse and how likely it is to survive.

Progression Rates and Survival

How fast ATTR gets worse and how long someone lives can change a lot. This depends on the mutation, type of ATTR, and if the heart or nerves are affected. Some mutations, like Val30Met, might make the disease progress slower. Knowing these differences helps doctors plan better treatments and manage what patients can expect.

Quality of Life Impact

ATTR really affects how well patients live their daily lives. It can make it hard to do everyday things, stay independent, and feel good overall. Getting diagnosed early and getting the right treatment is key to making patients’ lives better. We need to think about patients’ physical, emotional, and social needs.

Conclusion: Recognizing and Managing Transthyretin Amyloidosis

Transthyretin amyloidosis, or ATTR amyloidosis, is a complex condition. It happens when abnormal proteins build up in different organs. We’ve looked at its symptoms and how it affects the body.

Experts agree that early recognition and treatment are key to better outcomes (Adams et al., 2020). To manage ATTR well, we need to know its symptoms, how to diagnose it, and treatment options.

Understanding transthyretin amyloidosis helps doctors create specific treatment plans. This is important for patients with this condition.

As we learn more about ttr amyloidosis, we can get better at diagnosing and treating it. This will help improve the lives of those affected by this complex condition.

FAQ

What is transthyretin amyloidosis?

Transthyretin amyloidosis, or ATTR, is a condition where misfolded protein builds up in organs. This leads to various symptoms.

What are the common symptoms of transthyretin amyloidosis?

Symptoms include heart failure and arrhythmias. Also, peripheral neuropathy and autonomic nervous system issues. Diarrhea, nausea, weight loss, and gastrointestinal problems are common too.

How is transthyretin amyloidosis diagnosed?

Diagnosis involves genetic testing for TTR gene mutations. Tests like echocardiography and nerve conduction studies also assess organ damage and amyloid deposits.

What is the role of genetic testing in transthyretin amyloidosis?

Genetic testing is key to finding TTR gene mutations. It helps diagnose hereditary transthyretin amyloidosis. It also informs family members about their risk.

What is the difference between hereditary and wild-type ATTR?

Hereditary ATTR is caused by a TTR gene mutation and is inherited. Wild-type ATTR, on the other hand, occurs without a known genetic mutation. It’s more common in older adults.

Can transthyretin amyloidosis be treated?

There’s no cure, but treatments can manage symptoms and slow disease progression. These include medications, lifestyle changes, and sometimes organ transplantation.

What are the early warning signs of transthyretin amyloidosis?

Early signs include carpal tunnel syndrome, spinal stenosis, and joint issues. These can signal the onset of more severe symptoms.

How does transthyretin amyloidosis affect the heart?

It can cause heart failure, arrhythmias, and cardiomyopathy. These lead to structural changes in the heart.

What is the impact of transthyretin amyloidosis on quality of life?

It significantly affects quality of life. Symptoms impact daily activities, nutrition, and overall well-being.

Are there any geographic or ethnic patterns in the prevalence of transthyretin amyloidosis?

Yes, certain TTR gene mutations are more common in specific populations. The prevalence of ATTR varies by region and ethnicity.


References

National Center for Biotechnology Information. Evidence-Based Medical Guidance. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9313045/

Trusted Worldwide
30
Years of
Experience
30 Years Badge

With patients from across the globe, we bring over three decades of medical

Spec. MD. Serdar Kızılkaya Spec. MD. Serdar Kızılkaya Geriatrics
Patient Reviews
Reviews from 9,651
4,9

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Asst. Prof. MD. Begüm Aslan

Asst. Prof. MD. Begüm Aslan

MD. RÜSTEM VELİZADE

MD. Mustafa Altuntop

MD. Mustafa Altuntop

Psyc. (Psychologist) Buse Mamur

Psyc. (Psychologist) Buse Mamur

Assoc. Prof. MD.  Musa Çakıcı

Assoc. Prof. MD. Musa Çakıcı

Assoc. Prof. MD.  Handan Haydaroğlu Şahin

Assoc. Prof. MD. Handan Haydaroğlu Şahin

Asst. Prof. MD. Yusuf Emre Altundal

Spec. MD. Mustafa Sağcan

Spec. MD. Mustafa Sağcan

Op. MD. Yücel Polat

Op. MD. Yücel Polat

Prof. MD. Berna Tander

Prof. MD. Berna Tander

Op. MD. Emrah Dirican

Op. MD. Emrah Dirican

Assoc. Prof. MD. Meki Bilici

Assoc. Prof. MD. Meki Bilici

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health
Your Comparison List (you must select at least 2 packages)